10 September 2018
: Case report
A Case of Ocular Kaposi’s Sarcoma Successfully Treated with Highly Active Antiretroviral Therapy (HAART) Combined with Docetaxel
Mistake in diagnosis, Unusual or unexpected effect of treatment, Rare disease
Chongfei Jin12BCDEF*, Hamza Minhas3CDE, Amandeep Kaur1DEF, Sreenath Kodali3BC, Vladimir Gotlieb3AGDOI: 10.12659/AJCR.910374
Am J Case Rep 2018; 19:1074-1077
Abstract
BACKGROUND: Ocular Kaposi’s sarcoma (KS) involving the conjunctiva and ocular adnexa is uncommon and is usually treated with cryotherapy or surgical excision. We report a case of ocular KS successfully treated with HAART combined with 8 cycles of weekly docetaxel.
CASE REPORT: Our patient was a 24-year-old, treatment-naïve, HIV-positive (CD4 cell count 198 cells/mm3), homosexual man treated as having atypical hordeolum and subconjunctival hemorrhage, and later confirmed with pathology to have ocular KS with immunohistochemistry study showing KS with positive HHV8, CD34, CD31, and focal positive staining with Factor VIIIRA. HAART therapy was initiated combined with weekly docetaxel. With 2-month treatment of HAART and 8 cycles of weekly docetaxel, the KS of the bulbar conjunctiva and the eyelid partially resolved.
CONCLUSIONS: HAART combined with weekly docetaxel is an effective and well-tolerated option for ocular KS, which could be considered before cryotherapy or surgical excision.
Keywords: Anti-Retroviral Agents, Herpesvirus 8, Human, Sarcoma, Kaposi
794 2
In Press
21 Sep 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.941337
21 Sep 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.941422
21 Sep 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.941599
21 Sep 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.941877
Most Viewed Current Articles
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
07 Dec 2021 : Case report
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250